ValiRx (LON:VAL) Issues Quarterly Earnings Results

ValiRx (LON:VAL) posted its quarterly earnings data on Monday. The company reported GBX (0.54) earnings per share (EPS) for the quarter, Digital Look Earnings reports. The firm had revenue of GBX 3 million during the quarter. ValiRx had a negative return on equity of 45.91% and a negative net margin of 3,582.56%.

ValiRx Stock Down 0.6%

Shares of ValiRx stock opened at GBX 0.18 on Monday. The company has a 50-day simple moving average of GBX 0.23 and a two-hundred day simple moving average of GBX 0.30. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.27 and a current ratio of 9.66. ValiRx has a 52-week low of GBX 0.16 and a 52-week high of GBX 0.85. The stock has a market capitalization of £1.33 million, a PE ratio of -0.19 and a beta of 0.59.

About ValiRx

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.